Nexium Capsules Clinical Experience Investigation

Trial Profile

Nexium Capsules Clinical Experience Investigation

Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2017

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Duodenal ulcer; Gastric ulcer; Gastro-oesophageal reflux; Postoperative complications; Reflux oesophagitis; Zollinger-Ellison syndrome
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 27 Mar 2014 Status changed from active, no longer recruiting to completed as reported by
    • 09 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014as reported by
    • 08 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top